⌕
Billiontoone · BLLN · Nasdaq
Tenet — · insufficient data
Compare
$97.50+1.24%At close
$97.50+1.19 (+1.24%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.

Billiontoone (BLLN) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is BLLN's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● The Motley FoolNov 15, 2026 · 12:37 ET
BillionToOne: 3 Key Takeaways for Long-Term Investors

BillionToOne raised 2026 revenue guidance to $460 million to $470 million. Third-quarter revenue reached $123 million, up 47% year over year.…

BLLN +1.2% todayRead at source ↗
● Seeking AlphaNov 11, 2026 · 06:59 ET
BillionToOne, Inc. (BLLN) Presents at 2026 UBS Global Healthcare Conference Transcript

BillionToOne, Inc. ( BLLN ) 2026 UBS Global Healthcare Conference November 10, 2026 2:00 PM EST Company Participants Oguzhan Atay - Co-Founder, Chairman & CEO Presentation Unknown Analyst Good afternoon. I'm Doug Schenke…

BLLN +1.2% todayRead at source ↗
● Defense WorldNov 7, 2026 · 05:36 ET
Insider Selling: Billiontoone (NASDAQ:BLLN) CTO Sells $2,184,800.00 in Stock

Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) CTO David Tsao sold 20,000 shares of the stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $109.24, for a total value of $2…

BLLN +1.2% todayRead at source ↗
● Seeking AlphaNov 4, 2026 · 23:24 ET
BillionToOne, Inc. (BLLN) Q3 2026 Earnings Call Transcript

BillionToOne, Inc. (BLLN) Q3 2026 Earnings Call Transcript…

BLLN +1.2% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 21:01 ET
BillionToOne (BLLN) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Stre…

BLLN +1.2% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 20:46 ET
BillionToOne (BLLN) Surpasses Q3 Earnings and Revenue Estimates

BillionToOne (BLLN) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.1 per share a year ago.…

BLLN +1.2% todayRead at source ↗
● MarketBeatNov 4, 2026 · 19:21 ET
Billiontoone Q3 Earnings Call Highlights

Billiontoone NASDAQ: BLLN raised its full-year revenue outlook after third-quarter sales rose 47% from a year earlier, driven by growth in both prenatal and oncology testing. The molecular diagnostics company also report…

BLLN +1.2% todayRead at source ↗
● GlobeNewsWireNov 4, 2026 · 16:05 ETCOMPANY'S OWN WORDS
BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance

MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, to…

BLLN +1.2% todayRead at source ↗
● Seeking AlphaOct 29, 2026 · 14:15 ET
BillionToOne: New Kid On The Molecular Diagnostics Block Poised To Take Share

BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B market cap. BLLN's Unity Complete offers unmatched prenatal screening convenience and accuracy,…

BLLN +1.2% todayRead at source ↗
● Zacks Investment ResearchOct 28, 2026 · 11:06 ET
BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth

BillionToOne (BLLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

BLLN +1.2% todayRead at source ↗
● GlobeNewsWireOct 27, 2026 · 08:05 ETCOMPANY'S OWN WORDS
BillionToOne to Participate in Two Upcoming Investor Conferences

MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, to…

BLLN +1.2% todayRead at source ↗
● Defense WorldOct 19, 2026 · 04:22 ET
Billiontoone (NASDAQ:BLLN) CEO Sells $516,184.50 in Stock

Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) CEO Oguzhan Atay sold 5,150 shares of the business's stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $100.23, for a tot…

BLLN +1.2% todayRead at source ↗
● GlobeNewsWireOct 14, 2026 · 08:05 ETCOMPANY'S OWN WORDS
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026

MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, to…

BLLN +1.2% todayRead at source ↗
● Seeking AlphaOct 12, 2026 · 22:41 ET
BillionToOne: A Molecular Diagnostics Stock With Strong Quality And GARP Credentials

BillionToOne a molecular diagnostic company from California, has experienced quite a topsy-turvey journey since its debut in November last year. BLLN is set to hold on to a consistently high GMS of 70%, which reflects th…

BLLN +1.2% todayRead at source ↗
● GlobeNewsWireOct 7, 2026 · 07:00 ET
BillionToOne's Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response Head-to-head comparison shows 94% concordance with tum…

BLLN +1.2% todayRead at source ↗
● Defense WorldOct 2, 2026 · 06:41 ET
Billiontoone (NASDAQ:BLLN) Shares Down 4.6% After Insider Selling

Shares of Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) were down 4.6% on Wednesday after an insider sold shares in the company. The stock traded as low as $112.75 and last traded at $112.72. 74,648 shares changed …

BLLN +1.2% todayRead at source ↗
● BenzingaSep 23, 2026 · 14:09 ET
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

The Centers for Medicare & Medicaid Services plans to align its 2027 clinical laboratory fee schedule rates with private sector payer rates, aiming to curb excessive Medicare payments and save taxpayers an estimated $1 b…

BLLN +1.2% todayRead at source ↗
● The Motley FoolSep 21, 2026 · 08:56 ET
BillionToOne SVP Sells 1,416 Shares

The transaction involved 1,416 shares at a weighted average price of $97.54 per share, totaling $138,116 on Sept. 9, 2026. The sale involved shares equal to 5% of the direct equity position held before the transaction.…

BLLN +1.2% todayRead at source ↗
● The Motley FoolSep 17, 2026 · 13:15 ET
BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

The transaction involved 30,331 shares executed at a weighted average price of $99.91 per share on September 14, 2026. The shares traded in this filing represented 100% of the insider's directly-held equity stake, and a …

BLLN +1.2% todayRead at source ↗
● PRNewsWireSep 2, 2026 · 16:05 ETCOMPANY'S OWN WORDS
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference

MENLO PARK, Calif., Sept. 2, 2026 /PRNewswire/ -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today …

BLLN +1.2% todayRead at source ↗
● PRNewsWireSep 1, 2026 · 09:00 ETCOMPANY'S OWN WORDS
BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin

New add-on test from a single blood draw; BillionToOne also expands Northstar Select® panel to 102 genes MENLO PARK, Calif., Sept. 1, 2026 /PRNewswire/ -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular di…

BLLN +1.2% todayRead at source ↗
● The Motley FoolAug 28, 2026 · 13:12 ET
BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million

The transaction involved 10,000 shares at a weighted-average price of $100.00 per share, totaling $1.0 million on the August 25, 2026 transaction date. Following the disposal, the insider holds a direct position of 1,000…

BLLN +1.2% todayRead at source ↗
● GuruFocusAug 19, 2026 · 11:00 ET
/C O R R E C T I O N -- BillionToOne/

/C O R R E C T I O N -- BillionToOne/ PR Newswire MENLO PARK, Calif., Aug. 18, 2026 I…

BLLN +1.2% todayRead at source ↗
● PRNewsWireAug 18, 2026 · 12:08 ET
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions

Study of more than 2,200 pregnant carriers demonstrates strong clinical performance in the intended-use, general-risk population, with outcomes available for more than 98% of eligible cfDNA results MENLO PARK, Calif., Au…

BLLN +1.2% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA31−0.4%
WDAY4−5.8%
EG3−2.0%

Article counts from the last market-wide feed page, across every symbol we track and not just BLLN · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.